June 11, 2010Genta Incorporated Announces Webcast of 2010 Annual Shareholders Meeting
June 7, 2010Tesetaxel Results from Two Clinical Dose-Ranging Trials Presented at ASCO
June 6, 2010Pooled Results of Early Endpoints from Phase 3 Trials of Genasense® in Advanced Melanoma Presented at ASCO
May 13, 2010Genta Incorporated Announces First Quarter 2010 Financial Results
May 6, 2010Genta Incorporated to Host Conference Call to Discuss First Quarter 2010 Highlights and Financial Results
May 4, 2010Genta Announces Clinical Presentations on Lead Compounds, Tesetaxel and Genasense®, at 2010 Annual ASCO Meeting
